What is the intrinsic value of HGH.NZ?
As of 2025-06-06, the Intrinsic Value of Heartland Group Holdings Ltd (HGH.NZ) is
0.22 NZD. This HGH.NZ valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.77 NZD, the upside of Heartland Group Holdings Ltd is
-71.98%.
Is HGH.NZ undervalued or overvalued?
Based on its market price of 0.77 NZD and our intrinsic valuation, Heartland Group Holdings Ltd (HGH.NZ) is overvalued by 71.98%.
HGH.NZ Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
0.22 - 0.22 |
0.22 |
-71.98% |
| P/E |
0.48 - 1.41 |
0.85 |
10.6% |
| DDM - Stable |
0.22 - 0.39 |
0.30 |
-60.6% |
| DDM - Multi |
1.26 - 1.75 |
1.46 |
90.2% |
HGH.NZ Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
723.88 |
| Beta |
1.30 |
| Outstanding shares (mil) |
940.10 |
| Enterprise Value (mil) |
2,122.21 |
| Market risk premium |
5.10% |
| Cost of Equity |
12.46% |
| Cost of Debt |
5.00% |
| WACC |
5.94% |